The Utility of Transcutaneous Bilirubin Measurement in Newborns with Hyperbilirubinemia: A Prospective, Observational

Duygu Besnili Açar1, Seda Yilmaz Semerci2

  • 1Division of Neonatology, Department of Pediatrics, Istanbul Gaziosmanpasa Training and Research Hospital, Istanbul, Turkiye.

Insights

Transcutaneous bilirubin (TcB) measurements show moderate accuracy but tend to underestimate total serum bilirubin (TSB) levels in infants receiving phototherapy. TcB should not replace TSB testing during or after treatment.

Area of Science:

  • Neonatal Medicine
  • Pediatric Phototherapy
  • Bilirubin Metabolism

Background:

  • Jaundice is common in newborns, requiring monitoring.
  • Phototherapy is a standard treatment for neonatal hyperbilirubinemia.
  • Accurate bilirubin measurement is crucial for effective treatment.

Purpose of the Study:

  • To assess the accuracy of transcutaneous bilirubin (TcB) measurements compared to total serum bilirubin (TSB) levels.
  • To evaluate TcB accuracy during and after phototherapy in term and late-preterm infants.

Main Methods:

  • Prospective observational study involving 90 infants.
  • Paired TcB (glabella and abdomen) and TSB measurements were collected.
  • Bland-Altman analysis evaluated agreement between TcB and TSB.

Main Results:

  • A moderate correlation was observed between TcB and TSB levels.
  • TcB measurements consistently underestimated TSB values.
  • Significant variability existed between TcB and TSB measurements.

Conclusions:

  • TcB measurements have moderate agreement with TSB but are unreliable during/after phototherapy.
  • TcB cannot substitute for TSB testing in this clinical context.
  • Clinical decisions regarding phototherapy should rely on TSB levels.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...